FDA's Device Center Faces New Charge Of Whistleblower Retaliation

Federal officials took steps last week to reinstate a recently fired reviewer in FDA's diagnostics office, claiming that agency actions may have violated the Whistleblower Protection Act.

More from Archive

More from Medtech Insight